Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
174,468,831
-
Shares change
-
+3,467,652
-
Total reported value, excl. options
-
$2,245,228,885
-
Value change
-
+$49,717,801
-
Put/Call ratio
-
20%
-
Number of buys
-
102
-
Number of sells
-
93
-
Price
-
$12.87
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2021
248 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of 30 Jun 2021.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) had 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 174,468,831 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BROWN CAPITAL MANAGEMENT LLC, Sarissa Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., Camber Capital Management LP, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, PUTNAM INVESTMENTS LLC, and LSV ASSET MANAGEMENT.
This table shows the top 202 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.